Key result
Automatic Gain Control in Boston Scientific ICDs may cause VF undersensing after high-amplitude signals.
Why the study?
Does the Automatic Gain Control (AGC) algorithm in Boston Scientific ICDs lead to ventricular fibrillation undersensing in the setting of high-amplitude ventricular signals?
Does the Automatic Gain Control (AGC) algorithm in Boston Scientific ICDs lead to ventricular fibrillation undersensing in the setting of high-amplitude ventricular signals?
The Automatic Gain Control algorithm in Boston Scientific ICDs can rarely fail by inappropriately increasing the sensing threshold after high-amplitude signals, leading to potentially fatal undersensing of ventricular fibrillation.
Answers are grounded in this paper and cite their sources.
Raises caution for rare VF undersensing with AGC in Boston Scientific ICDs; hypothesis-generating case report requiring further study.
Implantable cardioverter–defibrillators (ICDs) are highly effective in detecting and terminating ventricular fibrillation (VF) 1,2. However, rare failures in the sensing algorithm may prevent therapy delivery. Boston Scientific devices use an Automatic Gain Control (AGC) algorithm that dynamically adjusts ventricular sensitivity based on preceding signal amplitude. Under specific conditions, AGC may increase the sensing threshold inappropriately and miss low-amplitude VF signals.
No takes yet. Share an insight, caveat, or question.
Shtembari et al. (2026) studied Ventricular fibrillation. Automatic Gain Control (AGC) algorithm in Boston Scientific ICDs was evaluated on Ventricular fibrillation undersensing. The Automatic Gain Control algorithm in Boston Scientific ICDs may inappropriately increase the sensing threshold after high-amplitude signals, causing undersensing of ventricular fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: